TrialCancer science2018

Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012.

Makoto Tahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.